Secukinumab and Expression of ACE2 in Affected Skin of Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Allergy and Clinical Immunology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Secukinumab Lowers Expression of ACE2 in Affected Skin of Patients With Psoriasis
J. Allergy Clin. Immunol 2020 Sep 28;[EPub Ahead of Print], JG Krueger, DF Murrell, S Garcet, K Navrazhina, PC Lee, E Muscianisi, A BlauveltFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.